Mark C Sleevi

Title: Mark C Sleevi: Innovator in Pharmaceutical Compositions

Introduction

Mark C Sleevi is a notable inventor based in Midlothian, VA (US), recognized for his contributions to the field of pharmaceutical compositions. With a total of six patents to his name, he has made significant advancements in the production and purification of important biochemical compounds.

Latest Patents

Among his latest patents, Sleevi has developed purified rhIGF-I/rhIGFBP-3 complexes and their method of manufacture. This innovation provides complexes of IGF-I and IGFBP-3 with new levels of purity, utilizing chromatographic techniques that effectively remove contaminants, including mass and charge variants of IGFBP-3. These new techniques enable the production of high-quality pharmaceutical compositions comprising IGF-I/IGFBP-3 complexes. Additionally, he has patented methods for the production of D-chiro-inositol (DCI) and the use of D-chiro inositol obtained therefrom. This invention relates to methods for the production and isolation of D-chiro-inositol from plant extracts, specifically providing a method to produce D-chiro-inositol from a precursor moiety through conversion in concentrated hydrochloric acid.

Career Highlights

Throughout his career, Mark C Sleevi has worked with prominent companies such as Insmed Incorporated and Whitby Research, Inc. His work has significantly impacted the pharmaceutical industry, particularly in the development of high-quality biochemical products.

Collaborations

Sleevi has collaborated with notable individuals in his field, including Gevork Minaskanian and Robert Plourde, Jr. These collaborations have contributed to the advancement of his research and innovations.

Conclusion

Mark C Sleevi's contributions to the field of pharmaceutical compositions through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of high-quality biochemical products in the industry.